Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000826095 | SCV000967597 | likely pathogenic | Upshaw-Schulman syndrome | 2018-02-20 | criteria provided, single submitter | clinical testing | The c.415-1G>A variant in ADAMTS13 has not been previously reported in individua ls with Familial thrombotic thrombocytopenic purpura and was absent from large p opulation studies. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Complete loss of activity of ADAMTS13 is associat ed with thrombotic thrombocytopenic purpura. In summary, although additional stu dies are required to fully establish its clinical significance, the c.415-1G>A v ariant is likely pathogenic for Familial thrombotic thrombocytopenic purpura in an autosomal recessive manner. ACMG/AMP Criteria applied: PVS1_Strong; PM2. |